Literature DB >> 17557875

Adverse effects of dyes used in sentinel node biopsy on immunocytochemical determination of hormone receptors in breast cancer cells.

Y A Masannat1, A M Shaaban, V Speirs, G Coast, P Jackson, K Horgan, A M Hanby.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17557875      PMCID： PMC1955060          DOI： 10.1136/jcp.2006.044974

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  15 in total

1.  Oestrogen and progesterone receptors in breast cancer: past, present and future.

Authors:  D M Barnes; A M Hanby
Journal:  Histopathology       Date:  2001-03       Impact factor: 5.087

Review 2.  Properties and characteristics of the dyes injected to assist axillary sentinel node localization in breast surgery.

Authors:  Y Masannat; H Shenoy; V Speirs; A Hanby; K Horgan
Journal:  Eur J Surg Oncol       Date:  2006-03-02       Impact factor: 4.424

3.  Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.

Authors:  Rache Simmons; Sarmela Thevarajah; Meghan B Brennan; Paul Christos; Michael Osborne
Journal:  Ann Surg Oncol       Date:  2003-04       Impact factor: 5.344

4.  Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

Authors: 
Journal:  Lancet       Date:  1998-05-16       Impact factor: 79.321

5.  Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.

Authors:  R M Simmons; S M Smith; M P Osborne
Journal:  Breast J       Date:  2001 May-Jun       Impact factor: 2.431

6.  A comparison of methylene blue and lymphazurin in breast cancer sentinel node mapping.

Authors:  Walter D Blessing; Alan J Stolier; Stephen C Teng; John S Bolton; George M Fuhrman
Journal:  Am J Surg       Date:  2002-10       Impact factor: 2.565

7.  Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.

Authors:  A E Giuliano; P I Haigh; M B Brennan; N M Hansen; M C Kelley; W Ye; E C Glass; R R Turner
Journal:  J Clin Oncol       Date:  2000-07       Impact factor: 44.544

8.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial.

Authors:  Robert E Mansel; Lesley Fallowfield; Mark Kissin; Amit Goyal; Robert G Newcombe; J Michael Dixon; Constantinos Yiangou; Kieran Horgan; Nigel Bundred; Ian Monypenny; David England; Mark Sibbering; Tholkifl I Abdullah; Lester Barr; Utheshtra Chetty; Dudley H Sinnett; Anne Fleissig; Dayalan Clarke; Peter J Ell
Journal:  J Natl Cancer Inst       Date:  2006-05-03       Impact factor: 13.506

Review 9.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

10.  Efficacy of methylene blue dye in localization of sentinel lymph node in breast cancer patients.

Authors:  Ashraf Nour
Journal:  Breast J       Date:  2004 Sep-Oct       Impact factor: 2.431
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.